摘要
由于年龄和基础疾病的原因,老年人肺炎的临床表现常不典型,多数起病隐匿常缺乏咳嗽、咳痰、发热、胸痛及肺部湿啰音等肺炎的特征性表现。厄他培南是种新型1β-甲基碳青酶烯类抗生素,具有抗菌谱广、药物代谢动力学参数优良、不良反应少等特点,
出处
《中华老年医学杂志》
CAS
CSCD
北大核心
2009年第10期845-846,共2页
Chinese Journal of Geriatrics
二级参考文献35
-
1孙铁英,刘兵,扬敏.社区获得性肺炎老年住院患者的临床分析[J].中华老年医学杂志,2005,24(2):100-102. 被引量:111
-
2[1]Kohler J, Dorso KL, Young K, et al. In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolate[J]. Antimicrob Agents Chemother, 1999,43:1170-1176
-
3[2]Friedland IR, Isaacs R, Mixson LA, et al. Use of surrogate antimicrobial agents to predict susceptibility to ertapenem[J]. Diagn Microbiol Infect Dis, 2002,43:61-64
-
4[3]Vetter N, Cambronero-Hernandez E, Rohlf J, et al. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia[J]. Clin Ther,2002,24:1770-1785
-
5[4]Aldridge KE. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes[J]. Diagn Microbiol Infect Dis, 2002,44:181-186
-
6[5]Fuchs PC, Barry AL, Brown SD. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers[J]. Antimicrob Agents Chemother,2001,45 : 1915-1918
-
7[6]Livermore DM, Carter MW, Bagel S, et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia[J]. Antimicrob Agents Chemother,2001,45:1860-1867
-
8[7]Goldstein EJ, Citron DM, Vreni Merriam C, et al. Comparative In vitro activities of ertapenem (MK-0826) against 1,001anaerobes isolated from human intra-abdominal infections[J].Antimicrob Agents Chemother, 2000,44: 2389-2394
-
9[8]Betriu C, Sanchez A, Palau ML, et al. In vitro activities of MK-0826 and 16 other antimicrobials against bacteroides fragilis group strains [J]. Antimicrob Agents Chemother, 2001,45;2372-2374
-
10[9]Cottagnoud P, Pfister M, Cottagnoud M, et al. Activities of ertapenem, a new long-acting carbapenem, against penicillinsensitive or -resistant pneumococci in experimental meningitis [J]. Antimicrob Agents Chemother, 2003,47 : 1943-1947
共引文献26
-
1田宜玄,解沛涛,刘俊保,苏长海.1例人工关节置换术后应用厄他培南致神经系统异常的病例分析及药学监护[J].疾病监测与控制,2023,17(1):4-7.
-
2于亮,王梅,李玉臣,袁军,张利,鲍文韬,贾健,张莹,吴鹏.2007~2010年泰安医院临床主要病原菌分布及两种主要非发酵菌的耐药分析[J].中华临床医师杂志(电子版),2011,5(16):4766-4769. 被引量:15
-
3张伟刚.无呼吸道症状老年性肺炎的临床特点分析[J].航空航天医药,2011,22(1):44-45. 被引量:1
-
4吕艳霞.厄他培南——治疗多重耐药菌感染的新选择[J].海峡药学,2007,19(1):62-64. 被引量:2
-
5王贤杰,冯霞,陈翠玲.左氧氟沙星序贯给药治疗社区获得性肺炎的疗效观察[J].海南医学,2007,18(4):83-84. 被引量:3
-
6华更红,罗丽,刘德龙,谢芳,张万斌.(2S,4S)-1-(4-硝基苄氧羰基)-2-[(3-烯丙氧羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇的合成工艺改进[J].化学试剂,2007,29(2):124-126. 被引量:3
-
7李领香,李杰茹.老年肺炎的防治[J].白求恩军医学院学报,2007,5(4):242-244. 被引量:10
-
8来小丹,刘松青,林彩.新型碳青霉烯类抗生素厄他培南[J].中国药业,2007,16(23):1-3. 被引量:17
-
9罗涛,黄文祥,吴利先.注射用法罗培南的体内抗菌活性[J].中国新药与临床杂志,2008,27(3):183-186.
-
10杜卫星.306例高龄肺炎临床特点回顾性分析[J].右江医学,2008,36(5):593-594.
同被引文献22
-
1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
-
2Marik PE.Aspiration pneumonitis and aspiratio pneumonia[J].N Engl J reed,2001,34(4):665.
-
3Pikus L,Levine MS,Yang YX,et al .Videofluoroseopic studies of swallowing dysfunction and the relative risk of pneumonia[J].AJR Am J Roentgenol,2003,18(10): 1613.
-
4Kattan JN,Villegas MV,Quinn JP.New developments car-bapenems[J].Clin Microbiol Infect,2008,14(12):1102-1111.
-
5Fong JJ,Rose L,Radigan EA.Clinical outcomes with ertap-enem as a first-line treatment option of lnfections caused byextended-spectrumβ-lactamase-producing gram-negative bac-teria[J].Ann Pharmacother,2012,46(3):347-352.
-
6Park YS,Adams-Haduch JM,Shutt KA.Clinical and micro-biologic characteristics of cephalosporin-resistant Escherichiacoli at three centers in the United States[J].Antimicrob A-gents Chemother,2012,56(4):1870-1876.
-
7Denis Frasca,Sandrine Marchand,Franck Petitpas,Pharma-cokinetics of ertapenem following lntravenous and subcutane-ous Infusions in patients[J].Antimicrob Agents Chemother,2010,54(2):924-926.
-
8TEPPLER H, GESSER RM, FRIEDLAND IR. Safety and tolerability of ertapenem [J]. Antimicrob Chemother, 2004, 53 (2) : 75-81.
-
9KOPPEL BS, HAUSER WA, POLITIS C, et al. Seizures in the critically ill: the role of imipenem[J]. Epilepsia 2001, 42 (12): 1590-1593.
-
10LIVERMORE DM, SEFTON AM, SCOTT GM. Properties and potential of ertapenem[J]. J Antimierob Chemother, 2003, 52(3 ) : 331-344.
引证文献3
-
1饶理强.怡万之治疗老年人吸入性肺炎疗效观察[J].吉林医学,2012,33(15):3206-3208.
-
2王桦,张艳芳,赵晟珣,袁公贤,马春薇,夏上.厄他培南治疗呼吸道感染疗效观察[J].中华医院感染学杂志,2012,22(18):4126-4128. 被引量:2
-
3才旭,沈维.厄他培南致谵妄症状3例并文献复习[J].中国新药与临床杂志,2014,33(2):154-156. 被引量:5
二级引证文献7
-
1汤昱,沈照波,靳秀红,李敏,张向峰.厄他培南治疗儿童重症社区获得性肺炎临床疗效[J].河南医学研究,2013,22(1):18-20. 被引量:2
-
2杨辉,张弨,邵宏.慢性肾功能不全患者使用厄他培南致神经系统不良反应的药学监护及文献分析[J].中国新药杂志,2015,24(8):958-960. 被引量:6
-
3陈燕,朱立勤.厄他培南致癫痫发作1例[J].中国医院药学杂志,2015,35(20):1889-1889. 被引量:2
-
4董悦,胡欣.厄他培南致中枢神经系统不良反应的文献分析[J].中国药物警戒,2015,12(11):674-678. 被引量:5
-
5葛新顺,耿荣.厄他培南在儿科门急诊感染性疾病的应用分析[J].中国小儿急救医学,2016,23(8):564-566. 被引量:1
-
6丰雯诗,王逸群,陈旭岩.厄他培南致视幻觉及癫痫发作1例并文献复习[J].中国感染与化疗杂志,2019,19(2):146-150. 被引量:4
-
7鲁建丽,张华芳,冯志仙.基于循证和德尔菲法构建老年住院患者谵妄预防策略[J].护理与康复,2020,19(2):1-4. 被引量:4
-
1万瑞香,曹玉,牛珉,刘涵云.头孢吡肟与头孢他啶对照治疗老年人肺炎临床疗效观察[J].中国药师,2004,7(5):384-386. 被引量:5
-
2周宁,任光明.甲磺酸加替沙星治疗老年人肺炎疗效分析[J].浙江临床医学,2012,14(4):423-424. 被引量:2
-
3何忠,张强,谭明旗.厄他培南治疗老年社区获得性肺炎的临床疗效和安全性[J].实用药物与临床,2013,16(3):229-231. 被引量:4
-
4曹常娣.不同剂量盐酸氨溴索辅助治疗老年人肺炎的临床分析[J].中国继续医学教育,2016,8(12):148-149. 被引量:10
-
5刘万森,刘兆伟.丁胺卡那霉素为主治疗老年人肺炎30例[J].疑难病杂志,2002,1(2):68-68.
-
6孙铁英.厄他培南初始经验性治疗老年肺炎的价值[J].中国实用内科杂志,2008,28(7):605-606. 被引量:9
-
7王桦,赵晟珣,张艳芳,马春薇,袁公贤,夏上.厄他培南治疗老年下呼吸道感染疗效观察[J].疑难病杂志,2012,11(9):705-707. 被引量:7
-
8张瑞,曹晓欧.利奈唑胺与厄他培南治疗中度糖尿病足的疗效比较[J].航空航天医学杂志,2016,27(6):702-704. 被引量:2
-
9顾春枫.不同剂量盐酸氨溴索辅助治疗老年人肺炎的疗效[J].医学与社会,2015,28(B06):189-190. 被引量:1
-
10李笑爽.利奈唑胺与厄他培南治疗肺炎旁胸腔积液的疗效比较[J].中国冶金工业医学杂志,2016,33(3):319-320.